Hourly refreshWed, Sep 2, 2026

Press Release Database

Recent press releases, indexed by topic.
Topic

Finance

25,078 press releases indexed under finance.

AllFinanceCryptoAISaaSHealthcareReal EstateEnergyRetailAutomotiveGamingMediaEducation
DownloadExcelTXT
Finance

Wealth Enhancement Announces Acquisition of Dickerson Jackson & Associates, a Hybrid RIA with over $376 Million in Client Assets

This partnership brings the firm's total client assets to more than $161.4 billion. MINNEAPOLIS, Sept. 1, 2026 /PRNewswire/ -- Wealth Enhancement, a national independent wealth management firm dedicated to enriching clients' lives, announced it has acquired the investment advisory...

Sep 1 · 12:00mlpr-prnewswire-wire
Finance

Biometric Identity Security Provider BIO-key Participates at H.C. Wainwright Global Investment Conference Sept. 15th and 17th

Biometric Identity Security Provider BIO-key Participates at H.C. Wainwright Global Investment Conference Sept. 15th and 17th

Sep 1 · 11:59GlobeNewswire
Finance · Energy

Hornbeck and Helix Complete Merger, Creating a Premier Integrated Offshore Services Company

Hornbeck Offshore Services, Inc. To Begin trading on NYSE Under "HOS" on September 2, 2026 HOUSTON and COVINGTON, La., Sept. 1, 2026 /PRNewswire/ -- Helix Energy Solutions Group, Inc. ("Helix") (NYSE: HLX) and Hornbeck Offshore Services, Inc. ("Hornbeck") today announced they have...

Sep 1 · 11:55PR Newswire
Finance · Healthcare

Emergent BioSolutions Awarded Contract Modification Valued at Approximately $24 Million for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted)

GAITHERSBURG, Md., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced a contract modification valued at approximately $24 million from the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS), to supply CYFENDUS ® (Anthrax Vaccine Adsorbed, Adjuvanted) for anthrax preparedness efforts. Anthrax remains a significant global biological threat due to its potential use in a bioterrorism event and its implications for public health and national security.

Sep 1 · 11:55GlobeNewswire
Finance

3 E Network Secures $1.2 Million Enterprise DDR4 Memory Sales Order

3E Network Secures $1.2 Million Enterprise DDR4 Memory Sales Order

Sep 1 · 11:50GlobeNewswire
Finance · Education

Gymshark, Debenhams Group, and Follett Higher Education Now Offer Sezzle at Checkout

Fitness, fashion, and fall semester: Sezzle’s merchant network reaches into the carts that refill every season Fitness, fashion, and fall semester: Sezzle’s merchant network reaches into the carts that refill every season

Sep 1 · 11:50GlobeNewswire
Finance · Energy

Kayne Anderson Energy Infrastructure Fund Announces Distribution of $0.09 Per Share for September 2026

HOUSTON, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) announced today a monthly distribution of $0.09 per share for September 2026. This distribution is payable to common stockholders on September 30, 2026 (as outlined in the table below).

Sep 1 · 11:50GlobeNewswire
Finance · AI

Black Book Identifies Three Underreported Healthcare IT Capital Signals ...

(PR-inside.com) Q3 2026 study finds human infrastructure, transaction authority and embedded capital are emerging as new sources of healthcare technology value beyond the AI model NEW YORK CITY, NY / ACCESS Newswire / September 1, 2026 / Black Book Research has identified three underreported healthcare IT investment signals that may increasingly influence valuation, deal structure and competitive defensibility through 2029. The new Healthcare IT Capital Signals Q3 2026 report examines what may be changing beneath the more visible narratives around AI funding, consolidation, recurring revenue and margin expansion. The study was designed to identify capabilities quietly influencing underwriting and strategic positioning before they ..

Sep 1 · 11:45PR-Inside
Finance

Class Action Alert: Levi & Korsinsky Reminds Intuit Inc. (INTU) Investors ...

(PR-inside.com) NEW YORK, NY / ACCESS Newswire / September 1, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Intuit Inc. (NASDAQ:INTU) securities. If you suffered a loss on your Intuit Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Intuit Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against Intuit Inc. that ..

Sep 1 · 11:45PR-Inside
Finance · Energy

XCF Global (NASDAQ:SAFX) Advances Commercial Execution: Produces 886,000+ ...

(PR-inside.com) Commercial Deliveries Underway: New Rise Reno is actively shipping orders to paying customers, currently at approximately 55,000 gallons per day. Dual Revenue Model Activated: More than 886,400 gallons produced to date, generating over 1.5 million D4 Renewable Identification Numbers (RINs), with XCF executing its first RIN monetization transaction at $2.27 per RIN. Pathway Toward Nameplate Capacity: Current operations demonstrate progress toward the facility's permitted nameplate production capacity of up to 38 million gallons per year. Major Q4 Catalyst: Sustainable aviation fuel (SAF) blending component production is currently targeted to begin in Q4 2026. HOUSTON, TX / ACCESS Newswire / September 1, 2026 / XCF ..

Sep 1 · 11:45PR-Inside
Finance

Heidmar Maritime Holdings Corp. Reports Results for the Second Quarter Ended June 30, 2026

ATHENS, Greece and NEW YORK, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Heidmar Maritime Holdings Corp. (the "Company" or "Heidmar") (NASDAQ: HMR) today reported its results for the quarter and six month period ended June 30, 2026.

Sep 1 · 11:45GlobeNewswire
Finance · AI

NorthStrive Biosciences Expands AI-Driven Drug Discovery Program with Yuva Biosciences, Advancing Four Novel AI-Discovered Compounds Toward Lead Nomination for Potential Cardiac Disease and Obesity Therapeutic Applications

NorthStrive Biosciences Expands AI-Driven Drug Discovery Program with Yuva Biosciences, Advancing Four Novel AI-Discovered Compounds Toward Lead Nomination

Sep 1 · 11:45GlobeNewswire
← Prev1232090Next →